NASDAQ:SGHT

Sight Sciences Stock Insider Trading

Healthcare > Medical - Devices

Buy SGHT

*Your capital is at risk

$4.34

+0 (+0%)

At Close: Jun 03, 2026

Sight Sciences Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at -37.99. In total, the insiders bought 1.69M and sold 606.87K SGHT shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	-37.99
● Buy	1.69M shares
● Sell	606.87K shares
51% Buy Activity Negligible or No Correlation
Buy Signal Low Confidence Feb 03, 2026 Analysis Breakdown: Signal is highly questionable due to a strongly contradictory negative Insider Power Score of -37.99. Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date	Type	Person	Role	Amount
Jul 03, 2025 Sell	Common Stock S-Sale	Badawi David Chief Technology Officer	Officer	5 679 Value: $23.7K
Jul 03, 2025 Sell	Common Stock S-Sale	Hayden Jeremy B. Chief Legal Officer	Officer	9 160 Value: $38.2K
Jul 02, 2025 Sell	Common Stock S-Sale	Bauerlein Alison Chief Financial Officer	C-Suite Officer	19 260 Value: $78.9K
Jul 02, 2025 Sell	Common Stock S-Sale	Link Matthew Chief Commercial Officer	Officer	4 889 Value: $20.0K
Jul 02, 2025 Sell	Common Stock S-Sale	Link Matthew Chief Commercial Officer	Officer	4 889 Value: $20.0K
Jul 02, 2025 Sell	Common Stock S-Sale	Bauerlein Alison Chief Financial Officer	C-Suite Officer	19 260 Value: $78.9K
Jul 01, 2025 Sell	Common Stock S-Sale	Badawi Paul President And CEO	CEO / President	23 637 Value: $98.1K
Jul 01, 2025 Sell	Common Stock S-Sale	Badawi Paul President And CEO	CEO / President	23 637 Value: $98.1K
Jun 06, 2025 Buy	Common Stock P-Purchase	Encrantz Staffan	Director	27 900 Value: $117.7K
Jun 05, 2025 Buy	Common Stock A-Award	Mazzacco Catherine Director	Director	30 952 Value: $130.0K
Jun 05, 2025 Buy	Common Stock A-Award	Mazzacco Catherine Director	Director	30 952 Value: $130.0K
Jun 05, 2025 Buy	Common Stock A-Award	Larsen-becker Brenda Jane Director	Director	30 952 Value: $130.0K
Jun 05, 2025 Buy	Common Stock A-Award	Rogers Erica J. Director	Director	30 952 Value: $130.0K
Jun 05, 2025 Buy	Common Stock A-Award	Fountain Tamara Director	Director	30 952 Value: $130.0K
Jun 05, 2025 Buy	Common Stock A-Award	Zurbay Donald Director	Director	30 952 Value: $130.0K
Jun 05, 2025 Buy	Common Stock A-Award	Zurbay Donald Director	Director	30 952 Value: $130.0K
Jun 05, 2025 Buy	Common Stock A-Award	Fountain Tamara Director	Director	30 952 Value: $130.0K
Jun 05, 2025 Buy	Common Stock A-Award	Rogers Erica J. Director	Director	30 952 Value: $130.0K
Jun 05, 2025 Buy	Common Stock A-Award	Larsen-becker Brenda Jane Director	Director	30 952 Value: $130.0K
Jun 05, 2025 Buy	Common Stock A-Award	Encrantz Staffan	Director	30 952 Value: $130.0K
Jun 05, 2025 Buy	Common Stock P-Purchase	Encrantz Staffan	Director	40 951 Value: $173.8K
Jun 05, 2025 Buy	Common Stock P-Purchase	Encrantz Staffan	Director	40 951 Value: $173.8K
Jun 05, 2025 Buy	Common Stock A-Award	Encrantz Staffan	Director	30 952 Value: $130.0K
Jun 04, 2025 Buy	Common Stock P-Purchase	Encrantz Staffan	Director	21 674 Value: $90.4K
Sep 21, 2022 Buy	Stock Option (Right to Buy) M-Exempt	Badawi David Chief Technology Officer	Officer	40 000 Value: $9K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT SIGHT SCIENCES, INC.

Sight Sciences, Inc., an ophthalmic medical device company, engages in the development and commercialization of surgical and nonsurgical technologies for the treatment of eye diseases. The company's products include OMNI Surgical System, a therapeutic device used by ophthalmic surgeons to reduce intraocular pressure in adult glaucoma patients; and TearCare System, a wearable eyelid technology for the treatment of dry eye disease (DED) for ophthal...

Read Full Profile Here